Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects
Clinical trial NCT05102552 · COMPLETED
Trial details
- NCT number
- NCT05102552
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2022-03-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.